Editas Medicine· @editasmed · X·· 2026-10-10AI 评分33
AI 导读
昨日,我们宣布已获批在澳大利亚启动 EDIT-401 用于杂合子家族性高胆固醇血症(HeFH)患者的 Phase 1/2 Strive™ 研究。点击此处阅读新闻稿:https://bit.ly/4jKSqZt。 #cardiovasculardisease #HeFH #geneediting #clinicaltrials
正文
Yesterday, we announced approval to initiate our Phase 1/2 Strive™ study of EDIT-401 in patients with Heterozygous Familial Hypercholesterolemia (HeFH) in Australia. Read the press release here: https://bit.ly/4jKSqZt.
#cardiovasculardisease #HeFH #geneediting #clinicaltrials
来源:Editas Medicine · x.com